Introduction
The usefulness of salicylates in rheumatic fever is unquestioned, though their undesirable sideeffects on the gastro-intestinal tract and on the special senses are a drawback in prolonged therapy. Attempts to find allied substances with a greater safety margin have been made and three compounds, salicylamide, sodium gentisate and y-resorcylic acid, have recently been introduced.
The treatment of rheumatic fever with ACTH and cortisone has been the subject of a number of general reviews1' 2 and will not be discussed in the present article. The cost and scarcity of these materials have stimulated a search for simpler compounds with a similar physiological action and a cinchoninic acid derivative (HPC) for which an ACTH-like activity is claimed, has been tried clinically in acute rheumatic fever. It rise to the disease. This conclusion he derived from the fact that trees of the Cinchonaceae grew readily in areas where intermittent fever was prevalent.
The theory that the chelate ring in salicylic acid is important for therapeutic activity is most attractive. The available information is limited, but the presence of this structure in salicylic acid, gentisic acid and HPC and the enhanced activity due to two such rings in y-resorcylic acid is very suggestive. The reduction of toxic effects when a hydroxvl group at position 5 is introduced into the molecule of salicylic acid, as in gentisic acid, offers promising possibilities, and the activity and toxic actions of a compound in which such a hydroxyl group had been introduced into the molecule of y-resorcylic acid would be interesting.
The four compounds which have been discussed are certainly developments in the treatment of acute rheumatic fever and large controlled clinical trials are now necessary for their assessment.
